[1] 中国卫生健康委疾病预防控制局.2019年全国法定传染病疫情概况[J].中国病毒病杂志,2020,10(4):245. [2] PEELING R W,BOERAS D I,MARINUCCI F,et al.The future of viral hepatitis testing:innovations in testing technologies and approaches[J].BMC Infect Dis,2017,17(S1):699. [3] 李媛,谭艳.ELISA检测血清HBsAg、抗-HCV、抗-TP、抗-HIV灰区设定的探讨[J].国际检验医学杂志,2017,38(6):810-812. [4] 李军民,冯陆,胡云芝.300例乙肝患者乙肝五项检验结果分析[J].中国医药科学,2012,2(5):130-131. [5] 李金明,张瑞.常用乙型病毒性肝炎血清学标志物检测结果报告解释及临床应用[J].中华检验医学杂志,2012,35(4):296-300. [6] GANEM D,PRINCE A M.Hepatitis B virus infection-natural history and clinical consequences[J].N Engl J Med,2004,350(11):1118-1129. [7] U.S.Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research.Guidance for Industry:Use of Nucleic Acid Tests on Pooled and Individual Samples from Donors of Whole Blood and Blood Components,including Source Plasma,to Reduce the Risk of Transmission of Hepatitis B Virus [Z/OL].Silver Spring:FDA.(2012-10). [8] MORETTI M,PIERETTI B,MASUCCI A,et al.Role of signal-to-cutoff ratios in hepatitis C virus antibody detection[J].Clin Vaccine Immunol,2012,19(8):1329-1331. [9] MAASOUMY B,BREMER B,RAUPACH R,et al.How to interpret borderline HCV antibody test results:a comparative study investigating four different anti-HCV assays[J].Viral Immunol,2014,27(1):7-13. [10] 国家卫生和计划生育委员会.2016年国家血液安全报告[M].北京:人民卫生出版社,2017. [11] 杨涛,牛丽彬,李玲,等.抗-HCV酶免筛查反应性献血者确证策略研究[J].中国输血杂志,2016,29(1):13-16. [12] KIELY P,KAY D,PARKER S,et al.The significance of third-generation HCV RIBA-indeterminate,RNA-negative results in voluntary blood donors screened with sequential third-generation immunoassays[J].Transfusion,2004,44(3):349-358. [13] SEO YS,JUNG ES,KIM JH,et al.Significance of anti-HCV signal-to-cutoff ratio in predicting hepatitis C viremia[J].Korean J Intern Med,2009,24(4):302-308. [14] 李金明.感染性疾病血清学检验中应重视对弱反应性标本的确认[J].中华检验医学杂志,2006,29(7):577-580. [15] 方欢英,郭金虎,姜鹏飞,等.第四代电化学发光HIV筛查试剂在AIDS诊断中的应用探讨[J].中国皮肤性病学杂志,2020,34(8):959-963. [16] 李玲.降低我国经输血传播病原体风险的血液筛查策略研究[D].北京:中国医学科学院北京协和医学院,2019:74-76. |